01-01-1970 12:00 AM | Source: Reuters
France's Sanofi to help Johnson & Johnson manufacture COVID-19 vaccine
PARIS - French healthcare company Sanofi will provide COVID-19 vaccine manufacturing support to U.S. peer Johnson & Johnson, Sanofi said on Monday.
Once authorized, Sanofi will provide Johnson & Johnson access to the established infrastructure and expertise of its vaccine manufacturing plant in Marcy l'Etoile, France, to formulate and fill vials of Johnson & Johnson's Janssen COVID-19 vaccine candidate in 2021 at a rate of approximately 12 million doses per month.
Latest News
`Two-thirds of Indian companies striving for better ...
India's government lifts ban on onion exports, sets ...
Ola Krutrim opens AI Cloud infrastructure for develo...
Asian Energy Services Limited Q4FY24: Reports signi...
IDBI Bank reports 55% rise in profits on YoY basis
Accumulate Symphony Ltd Target Rs. 1,151 - Geojit Fi...
`Markets can turn volatile in the near term`
India`s Kotak Mahindra Bank beats estimates with 26%...
Coming Week's Market Report from Arvinder Singh Nand...
Nifty, Bank Nifty and Stocks to watch out 04.05.2024...